TARRYTOWN, N.Y.--(BUSINESS WIRE)--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the appointment of Peter J. Crowley to its Board of Directors as an independent director. A senior healthcare investment banker with over 20 years’ experience in the industry, Mr. Crowley will also serve on the Company’s Audit Committee.
